Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Jul 17, 2019, 08:00 ET Halozyme Announces First Clinical Dosing In argenx's Phase 1 Trial Of Efgartigimod (ARGX-113) With ENHANZE® Drug Delivery Technology

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, today announced that...


Jul 17, 2019, 07:30 ET U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension

Allergan plc (NYSE: AGN), a leading global pharmaceutical company with more than 70 years of heritage in eye care, today announced that the U.S. Food ...


Jul 17, 2019, 07:30 ET Elios Therapeutics Announces Positive Top-Line Data from Phase IIb Study Evaluating TLPLDC, a Personalized Therapeutic Cancer Vaccine, in Patients with High-Risk Melanoma

Elios Therapeutics, a biopharmaceutical company developing innovative autologous, particle-delivered, dendritic cell cancer vaccines, today announced ...


Jul 17, 2019, 07:00 ET EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38α Kinase Inhibitor Neflamapimod on the Neurodegenerative Process

EIP Pharma, Inc., a CNS-focused therapeutics company, today announced that new preclinical data regarding neflamapimod were presented at the AAIC...


Jul 17, 2019, 07:00 ET Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced that...


Jul 17, 2019, 07:00 ET Marker Therapeutics to Host Conference Call and Webcast to Review Interim Results from Phase 1/2 Clinical Trial with its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma

Marker Therapeutics, Inc. (NASDAQ:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based...


Jul 16, 2019, 17:20 ET Mallinckrodt Halts Phase 2B Trial Investigating the Use of Acthar® Gel (Repository Corticotropin Injection) in Amyotrophic Lateral Sclerosis (ALS)

Mallinckrodt plc (NYSE: MNK), a leading global specialty biopharmaceutical company, today announced that it is permanently discontinuing its Phase 2B ...


Jul 16, 2019, 16:15 ET Tradipitant Effective in Preventing Motion Sickness

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that tradipitant, a neurokinin-1 receptor antagonist, was effective in treating...


Jul 16, 2019, 16:05 ET Inovio Sharpens Focus On HPV-Related Diseases And Fast-to-Market Product Candidates

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today that it has sharpened its corporate strategy to focus on the commercial development of its ...


Jul 16, 2019, 14:00 ET KYSLECEL™ with 24-hour expiration time improves access to chronic pancreatitis treatment across the United States

Koligo Therapeutics, Inc. announced that it has made KYSLECEL (autologous pancreatic islets) with a 24-hour expiration time available throughout the...


Jul 16, 2019, 12:30 ET Athira Pharma Presents Preliminary Results from Phase 1 Trial of NDX-1017 at Alzheimer's Association International Conference 2019 (AAIC)

Athira Pharma, Inc., a clinical-stage company dedicated to developing first-in-class therapies for Alzheimer's and Parkinson's that are focused on...


Jul 16, 2019, 10:09 ET Seed Health Joins Microbiome Therapeutics Innovation Group

The Microbiome Therapeutics Innovation Group (MTIG) announced today the addition of Seed Health to its coalition of companies leading the research...


Jul 16, 2019, 09:07 ET QuartzBio™, Part Of Precision For Medicine, Expands Computational Biology And Launches Boston Office

QuartzBio™, part of Precision for Medicine, today announced a significant expansion of its computational biology and multiomic data integration...


Jul 16, 2019, 08:58 ET Parkinson's Foundation Launches First-of-its-Kind Free Genetic Testing Initiative for People with Parkinson's Disease

The Parkinson's Foundation is pleased to announce the launch of PD GENEration: Mapping the Future of Parkinson's Disease, a first-of-its-kind...


Jul 16, 2019, 08:00 ET Soliton Announces Submission for IRB Approval of Pivotal Cellulite Trial Protocol

Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from...


Jul 16, 2019, 08:00 ET Ambrx to receive milestone payment from Bristol-Myers Squibb for the initiation of Phase 1 Clinical Trial of a long-acting Relaxin derivative

Ambrx Inc. today announced that Bristol-Myers Squibb Company ("BMS") has initiated a phase I clinical trial to evaluate the safety, pharmacokinetics...


Jul 16, 2019, 08:00 ET Astellas and Seattle Genetics Announce Submission of Biologics License Application to FDA for Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and Seattle Genetics, Inc. (Nasdaq:SGEN) today announced...


Jul 16, 2019, 07:55 ET Digital therapeutics leader Biofourmis to take part in pioneering heart failure research with Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI)

Biofourmis, a fast-growing global leader in digital therapeutics, has entered a research partnership with the Yale University-Mayo Clinic Center of...


Jul 16, 2019, 07:38 ET Compugen Expands Intellectual Property Portfolio for COM701 with New U.S. Patent Covering Combination Use with anti-PD-1 Antibody

Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced today that the...


Jul 16, 2019, 07:30 ET BiondVax Announces Rights Offering Fully Subscribed at US$20 Million

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is proud to announce today the results of its previously announced rights offering. The Company has...


Jul 16, 2019, 07:30 ET Clinical Trials Market is Projected to Record a 4.5% CAGR Through 2029 - Future Market Insights

A new study of Future Market Insights (FMI) estimates the global spending on clinical trials in 2019 at ~US$ 90 Bn, recording a ~4% Y-o-Y over 2018....


Jul 16, 2019, 07:00 ET Anixa Biosciences Highlights Recent Publication in The Journal of Experimental Medicine on Myeloid Derived Suppressor Cells

Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system to fight cancer, today announced it...


Jul 16, 2019, 05:00 ET Human Pancreas on a Chip Opens New Possibilities for Studying Disease

Scientists created human pancreas on a chip that allowed them to identify the possible cause of a frequent and deadly complication of cystic fibrosis ...


Jul 16, 2019, 03:00 ET SurgiMab Advances SGM-101, a Novel Fluorescent Tumor-specific Antibody, Into Pivotal Phase 3 Clinical Trial to Improve Surgical Outcomes in Colorectal Cancer Patients

SurgiMab, a late-stage biotechnology company pioneering a new antibody-based fluorescence-guided approach designed to improve cancer surgery and...


Jul 16, 2019, 02:39 ET Grifols presents additional encouraging Alzheimer's trial results at AAIC

The Grifols Clinical Research team, led by Dr. Antonio Páez, today presented additional results of its AMBAR (Alzheimer Management by Albumin...